Wednesday Jan 28, 2026
Wednesday Jan 28, 2026
Wednesday, 28 January 2026 00:04 - - {{hitsCtrl.values.hits}}
Nihon Kohden’s team with College of Emergency Medicine President Dr. Inuka Wijewardena (third from left), at the Sri Lanka College of Emergency Physicians’ Annual Academic Congress 2025
Nihon Kohden Singapore, a leading global medical device manufacturer from Japan, together with its local partner Hemas Surgicals and Diagnostics Ltd., has introduced the Cereb Air, a next-generation EEG monitoring solution, at the Annual Scientific Conference of the Sri Lanka College of Emergency Physicians (SLCEP).
The event, brought together leading emergency medicine professionals, researchers, and healthcare stakeholders from across the country.
As platinum sponsor of the conference, Nihon Kohden highlighted its commitment to advancing neurological care by showcasing the Cereb Air.
Nihon Kohden Global Product Manager for Neurology Alejandro Ravago delivered a keynote presentation under the theme “New Generation EEG Monitoring.” He emphasised the device’s portability, wireless functionality, and advanced data analytics, capabilities not found in conventional EEG systems. The presentation was met with strong interest and appreciation from participants, reflecting the growing demand for advanced neurological diagnostic tools in emergency care settings.
Hemas Pharmaceuticals Managing Director Dr Mahesha Ranasoma said: “As a chapter in our mission to ‘Making Premium Healthcare Affordable’ for everyone, we’re invested in supporting strategies and developments that will effectively safeguard and protect lives. Our collaboration with Nihon Kohden Singapore, and their outstanding work on the Cereb Air, resonates with many of our shared goals and values in not only saving lives, but also advancing healthful living for all.”
During the event, Sri Lanka College of Emergency Physicians President Consultant Dr. Inuka Wijegunawardena, engaged in a discussion with the Nihon Kohden team on initiating a field study with the Cereb Air. This study would explore its potential to enable rapid and accurate diagnosis of seizures among head injury patients, an area where timely clinical intervention could save lives. The collaboration also aims to assess the economic benefits for hospitals by reducing the need for unnecessary radiological imaging and avoiding preventable admissions.
A spokesperson for Hemas Surgicals and Diagnostics said: “We are proud to partner with Nihon Kohden to introduce Cereb Air to Sri Lanka. This technology represents a milestone in emergency neurology care, offering physicians a faster and more accurate diagnostic tool while helping hospitals manage costs effectively. At Hemas, we remain dedicated to bringing the world’s best healthcare innovations to Sri Lanka and supporting the medical community in improving patient outcomes.”
For over 70 years, Nihon Kohden has been at the forefront of developing medical devices that support life-saving care across neurology, cardiology, and patient monitoring. Its products are trusted in hospitals worldwide for reliability, precision, and innovation. The launch of the Cereb Air in Sri Lanka marks another step in the company’s mission to provide advanced, accessible healthcare solutions tailored to the needs of emerging markets.
